Press Releases from SMi Conferences (2 total)
New Horizon for Treatment of Inherited Retinal Dystrophy
Over the past twelve months there has been significant advancements in cell gene therapy for inherited retinal dystrophy, with an FDA approval of Spark Therapeutics’ Voretigene – the first gene therapy approved in ophthalmology. The company’s Clinical Ophthalmic Lead, Daniel Chung will be speaking at the 2nd annual Ophthalmic Drugs Conference in London on 26th November, where he will share his experiences on the development of Voretigene and its success.…
New Technologies to Provide Connected Controlled Logistics
SMi proudly presents the 13th annual Cold Chain Distribution Conference taking place at the Copthorne Tara Hotel in Kensington, London between the 10th - 11th December.
The focus of the event will be the recent advances in temperature-controlled logistic solutions and the impact of regulatory changes on this multi-billion-dollar industry. Digitalisation of the industry will be discussed in detail and how the industry, from biotechs to pharma, need to adapt. Also,…
